Blaustein Marc
Chief Operating Officer at Finch Therapeutics Group, Inc.
- Sold, on record
- $7k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Feb 21, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Finch Therapeutics Group, Inc.Chief Operating Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Finch Therapeutics Group, Inc.Plan not statedOct 21, 2022 2022
Sold 3,636 shares at $1.39 ($5k)
Blaustein Marc, Chief Operating Officer
Sold 10% of holdings ($50k position)32,614 shares leftFirst sale on recordFiling
- 2 Form 4 sale Finch Therapeutics Group, Inc.Plan not statedFeb 21, 2023 +123 days
Sold 4,619 shares at $0.38 ($2k)
Blaustein Marc, Chief Operating Officer
Sold 14.2% of holdings ($12k position)27,995 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Feb 23, 2023 | Finch Therapeutics Group, Inc. | Chief Operating Officer | Form 4 sale | 4,619 | $2k | 14.2% | Plan not stated | SEC |
| Oct 21, 2022 | Oct 25, 2022 | Finch Therapeutics Group, Inc. | Chief Operating Officer | Form 4 sale | 3,636 | $5k | 10.0% | Plan not stated | SEC |